Taken together, FABP4 represents a mechanism by which obesity promotes obesity-associated breast carcinogenesis and development through multiple bioprocesses, including supporting interactions among cancer cells, adipocytes, and tumor-associated macrophages and connecting adipokines to oncogenic signaling. The gene discussed is FABP4; the disease is obesity due to melanocortin 4 receptor deficiency.